CARDIOPULMONARY BYPASS
Clinical trials for CARDIOPULMONARY BYPASS explained in plain language.
Never miss a new study
Get alerted when new CARDIOPULMONARY BYPASS trials appear
Sign up with your email to follow new studies for CARDIOPULMONARY BYPASS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut health pill aims to shield heart surgery patients
Disease control ENROLLING_BY_INVITATIONThis study is testing whether a probiotic supplement called Probacine can help protect patients' gut health and prevent organ problems after heart surgery. Researchers will enroll 500 adults undergoing cardiovascular surgery to see if the supplement improves recovery. The goal is…
Matched conditions: CARDIOPULMONARY BYPASS
Phase: NA • Sponsor: Nanjing Medical University • Aim: Disease control
Last updated Apr 02, 2026 05:12 UTC
-
One shot to shield kidneys from surgery damage?
Disease control OngoingThis study is testing whether a single dose of the drug ravulizumab can protect the kidneys of people with chronic kidney disease who are having planned heart surgery. The goal is to prevent serious kidney injury and related complications that can occur after surgery. About 736 p…
Matched conditions: CARDIOPULMONARY BYPASS
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New strategy aims to protect Kids' hearts in critical hours after surgery
Disease control ENROLLING_BY_INVITATIONThis study is testing a new, detailed care plan for children recovering from heart surgery. The plan focuses on carefully balancing oxygen levels in the body during the first 8 critical hours after surgery. Researchers hope this approach will help children's hearts recover better…
Matched conditions: CARDIOPULMONARY BYPASS
Phase: NA • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC